Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia.
about
Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin up-titration in Chinese patients with type 2 diabetes mellitus: study design and rationale of the vision studyCB1 receptor antagonists: new discoveries leading to new perspectives.Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects.
P2860
Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia.
@ast
Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia.
@en
Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia.
@nl
type
label
Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia.
@ast
Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia.
@en
Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia.
@nl
prefLabel
Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia.
@ast
Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia.
@en
Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia.
@nl
P2093
P2860
P356
P1433
P1476
Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia.
@en
P2093
Changyu Pan
Hyung Joon Yoo
Low-Tone Ho
P2860
P304
P356
10.1155/2011/957268
P577
2010-12-29T00:00:00Z